Facilities

Facilities

PISCATAWAY, New Jersey

Kashiv BioSciences’ 50,000 sq. ft. R&D facility has capabilities for mammalian cell line development, advanced analytical characterization, bioassay development, and small-scale manufacturing of complex proteins and monoclonal antibodies.

kashiv_facilities_piscataway-3

Analytical Characterization Lab

kashiv_facilities_piscataway-5

Cell Line Process Development

kashiv_facilities_piscataway-4

Biosimilar R&D Facility

CHICAGO, ILlinois

Kashiv BioSciences’ 100,000 sq.ft. R&D and manufacturing facility has capabilities for development and manufacturing of commercial-scale microbial cell lines, drug substance, and a fill and finish line for prefilled syringes and vials.  It is an FDA-registered site and complies fully with Local, State, and Federal Agencies, OSHA, EPA, and cGMP Standards.

kashiv_contact_3-chicago-5

Upstream Production Suite

kashiv_contact_3-chicago-6

Injectable Fill and Finish Line

kashiv_facilities_chicago-3

Biosimilar R&D and Injectable Manufacturing Facility

AHMEDABAD, GUJARAT, INDIA

Kashiv BioSciences’ 125,000 sq.ft. R&D facility contains state-of-the-art analytical labs for characterization, stability, bioassay development, process development, and small scale manufacturing of complex proteins for biosimilars. This site also conducts R&D for prodrugs and 505(b)(2) programs.

kashiv_facilities_india-3

India office and R&D facility

kashiv_facilities_india-4

Advanced analytical suites for biosimilar, 505(b)(2), and prodrug development

kashiv_facilities_india-6

Analytical labs equipped with the latest technology